Patient Support Program


Apremilast is indicated for the treatment of adult patients with: moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy; active psoriatic arthritis in patients who have had an inadequate response, intolerance, or contraindication to a prior disease-modifying anti-rheumatic drug (DMARD), and oral ulcers associated with Behçet’s disease who are candidates for systemic therapy,

Download the product monograph for contraindications, warnings, precautions, adverse reactions, interactions, dosing, and conditions of clinical use.